Wet Macular Degeneration

"Wet Macular Degeneration" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A form of RETINAL DEGENERATION in which abnormal CHOROIDAL NEOVASCULARIZATION occurs under the RETINA and MACULA LUTEA, causing bleeding and leaking of fluid. This leads to bulging and or lifting of the macula and the distortion or destruction of central vision.

Descriptor ID	D057135
MeSH Number(s)	C11.768.585.439.622
Concept/Terms	Wet Macular Degeneration Wet Macular Degeneration Degeneration, Wet Macular Degenerations, Wet Macular Macular Degeneration, Wet Macular Degenerations, Wet Wet Macular Degenerations

Below are MeSH descriptors whose meaning is more general than "Wet Macular Degeneration".

Diseases [C]
Eye Diseases [C11]
Retinal Diseases [C11.768]
Retinal Degeneration [C11.768.585]
Macular Degeneration [C11.768.585.439]
Wet Macular Degeneration [C11.768.585.439.622]

Below are MeSH descriptors whose meaning is related to "Wet Macular Degeneration".

Below are MeSH descriptors whose meaning is more specific than "Wet Macular Degeneration".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Wet Macular Degeneration" by people in this website by year, and whether "Wet Macular Degeneration" was a major or minor topic of these publications.

Bar chart showing 51 publications over 12 distinct years, with a maximum of 11 publications in 2020

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2011	2	1	3
2012	4	0	4
2013	3	1	4
2014	3	0	3
2015	6	0	6
2016	1	0	1
2017	2	0	2
2018	3	1	4
2019	6	0	6
2020	11	0	11
2021	3	0	3
2022	4	0	4

Below are the most recent publications written about "Wet Macular Degeneration" by people in Profiles.

Bui YT, Starr MR, Kung FF, Mejia CA, Bakri SJ. Long-Term Visual Outcomes in Exudative Age-Related Macular Degeneration Patients With Unanticipated Gaps in Therapy. Ophthalmic Surg Lasers Imaging Retina. 2022 09; 53(9):481-489.

View in: PubMed
Shah SM, Boopathiraj N, Starr MR, Dalvin LA, AbouChehade J, Damento G, Garcia MD, Hodge DO, Bakri SJ, Sit AJ, Iezzi R. Risk, Prevalence, and Progression of Glaucoma in Eyes With Age-Related Macular Degeneration Treated With Intravitreal Anti-Vascular Endothelial Growth Factor Injections. Am J Ophthalmol. 2022 11; 243:98-108.

View in: PubMed
Sharma A, Parachuri N, Kumar N, Kuppermann BD, Bandello F, Regillo CD. The port delivery system with ranibizumab: understanding nuances for clinical use in the real world. Expert Opin Biol Ther. 2022 06; 22(6):675-677.

View in: PubMed
Regillo C, Singh R, Hamilton R, Gedif K, Best C, Koh A, Holz FG. Fluid Control in Neovascular Age-Related Macular Degeneration with Brolucizumab: An Analysis of the HAWK and HARRIER Phase 3 Trials. Ophthalmologica. 2022; 245(5):403-412.

View in: PubMed
Holekamp NM, Campochiaro PA, Chang MA, Miller D, Pieramici D, Adamis AP, Brittain C, Evans E, Kaufman D, Maass KF, Patel S, Ranade S, Singh N, Barteselli G, Regillo C. Archway Randomized Phase 3 Trial of the Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration. Ophthalmology. 2022 03; 129(3):295-307.

View in: PubMed
Aslanis S, Amr?n U, Lindberg C, Epstein D. Recurrent Neovascular Age-Related Macular Degeneration after Discontinuation of Vascular Endothelial Growth Factor Inhibitors Managed in a Treat-and-Extend Regimen. Ophthalmol Retina. 2022 01; 6(1):15-20.

View in: PubMed
Starr MR, Xu D, Boucher N, Saroj N, Patel LG, Ammar M, Pandit RR, Jenkins TL, Ho AC. Characterizing Progression to Neovascular AMD in Fellow Eyes of Patients Treated With Intravitreal Anti-VEGF Injections. Ophthalmic Surg Lasers Imaging Retina. 2021 03; 52(3):123-128.

View in: PubMed
Sharma A, Parachuri N, Kumar N, Bandello F, Kuppermann BD, Loewenstein A, Regillo C, Chakravarthy U. Fluid-based prognostication in n-AMD: Type 3 macular neovascularisation needs an analysis in isolation. Br J Ophthalmol. 2021 03; 105(3):297-298.

View in: PubMed
Ho AC, Kleinman DM, Lum FC, Heier JS, Lindstrom RL, Orr SC, Chang GC, Smith EL, Pollack JS. Baseline Visual Acuity at Wet AMD Diagnosis Predicts Long-Term Vision Outcomes: An Analysis of the IRIS Registry. Ophthalmic Surg Lasers Imaging Retina. 2020 11 01; 51(11):633-639.

View in: PubMed
Sharma A, Parachuri N, Kumar N, Bandello F, Kuppermann BD, Loewenstein A, Regillo CD, Chakravarthy U. Notion of tolerating subretinal fluid in neovascular AMD: understanding the fine print before the injection pause. Br J Ophthalmol. 2021 02; 105(2):149-150.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement